EB-1A Sustained โ Pharmaceutical Sciences (2019): the AAO, upon de novo review, found the petitioner
Filing your own EB-1A? See how your CV maps to the criteria this decision turned on โ free strategy preview.
Decision Summary
The appeal was sustained because the AAO, upon de novo review, found the petitioner established eligibility through the totality of the evidence. While the Director initially denied the case at the final merits stage despite acknowledging the petitioner met three criteria (judging, scholarly articles, and high salary), the AAO determined that the petitioner's role on an international scientific advisory council, among other evidence, demonstrated the requisite sustained national or international acclaim.
See how a decision like this gets cited in an EB-1A petition →Criteria Discussed
Sign up free to download the original PDF
Downloaded the case? Use it in your next draft →Filing your own EB-1A? See what made this petition succeed.
Upload your CV and see how your profile maps to the criteria the AAO sustained here โ free strategy preview, no credit card.
Map Your CV to These Criteria โNo credit card required.